“…The cytokines and chemokines in neutrophil granules may recruit additional cells and are capable of effecting protumoral and anti-tumoral activity (Table 2). TANs have been identified in hematological (Hodgkin and non-Hodgkin anaplastic lymphomas [37,38], plasmacytoma [39], histiocytic sarcoma [40]), epithelial (esophageal [41], gastric [42], pancreaticobiliary [43,44], lung [45], head and neck squamous [36], breast [46,50], renal [47], urinary bladder carcinomas [48]) and germ cell [49] malignancies. In some settings, the neutrophilic influx into tumors has been described as 'pyogenic' [37], 'suppurative' [60] or an 'abscess' [38][39][40]46] in clinical and histopathological presentations.…”